Refine
Language
- English (14)
Is part of the Bibliography
- yes (14)
Keywords
- cancer (3)
- Mediterranean diet (2)
- Mendelian randomization (2)
- database (2)
- disease (2)
- genes (2)
- gwas (2)
- heart (2)
- loci (2)
- risk (2)
- variants (2)
- Adult height (1)
- Blood pressure (1)
- Chronic diseases (1)
- Cohort studies (1)
- Confidence intervals (1)
- Determinants (1)
- Diabetes incidence (1)
- Dietary assessment (1)
- Dietary questionnaires (1)
- Dietary recalls (1)
- EPIC-Potsdam study (1)
- Epidemiologic studies (1)
- Food choice (1)
- Food frequency questionnaire (1)
- Food intake (1)
- Heterogeneity (1)
- Large-scale studies on food intake (1)
- Leg length (1)
- Liver fat (1)
- Meta-analyses (1)
- Model comparison (1)
- Nordic diet (1)
- NutriAct family study (1)
- Reclassification (1)
- Risk assessment (1)
- Risk model (1)
- Short stature (1)
- Statistical modelling (1)
- Study protocol (1)
- Trunk length (1)
- Umbrella review (1)
- breast cancer (1)
- chronic diseases (1)
- colorectal cancer (1)
- confidence intervals (1)
- diabetes (1)
- diet-disease association (1)
- dietary patterns (1)
- epidemiology (1)
- longitudinal analysis (1)
- meta-analysis (1)
- metabolomics (1)
- model comparison (1)
- myocardial infarction (1)
- principal component analysis (1)
- prostate cancer (1)
- reclassification (1)
- regional diets (1)
- replication (1)
- risk assessment (1)
- risk model (1)
- stroke (1)
- type 2 diabetes mellitus (1)
The Net Reclassification Improvement (NRI) has become a popular metric for evaluating improvement in disease prediction models through the past years. The concept is relatively straightforward but usage and interpretation has been different across studies. While no thresholds exist for evaluating the degree of improvement, many studies have relied solely on the significance of the NRI estimate. However, recent studies recommend that statistical testing with the NRI should be avoided. We propose using confidence ellipses around the estimated values of event and non-event NRIs which might provide the best measure of variability around the point estimates. Our developments are illustrated using practical examples from EPIC-Potsdam study.
Background: Most studies on food choice have been focussing on the individual level but familial aspects may also play an important role. This paper reports of a novel study that will focus on the familial aspects of the formation of food choice among men and women aged 50-70 years by recruiting spouses and siblings (NutriAct Family Study; NFS). Discussion: Until August 4th 2017, 4783 EPIC-Participants were contacted by mail of which 446 persons recruited 2 to 5 family members (including themselves) resulting in 1032 participants, of whom 82% had started answering or already completed the questionnaires. Of the 4337 remaining EPIC-participants who had been contacted, 1040 (24%) did not respond at all, and 3297 (76%) responded but declined, in 51% of the cases because of the request to recruit at least 2 family members in the respective age range. The developed recruitment procedures and web-based methods of data collection are capable to generate the required study population including the data on individual and inter-personal determinants which will be linkable to food choice. The information on familial links among the study participants will show the role of familial traits in midlife for the adoption of food choices supporting healthy aging.
Aims/hypothesis This study aimed to evaluate associations of height as well as components of height (sitting height and leg length) with risk of type 2 diabetes and to explore to what extent associations are explainable by liver fat and cardiometabolic risk markers. Methods A case-cohort study within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study comprising 26,437 participants who provided blood samples was designed. We randomly selected a subcohort of 2500 individuals (2029 diabetes-free at baseline and with anamnestic, anthropometrical and metabolic data for analysis). Of the 820 incident diabetes cases identified in the full cohort during 7 years of follow-up, 698 remained for analyses after similar exclusions. Results After adjustment for age, potential lifestyle confounders, education and waist circumference, greater height was related to lower diabetes risk (HR per 10 cm, men 0.59 [95% CI 0.47, 0.75] and women 0.67 [0.51, 0.88], respectively). Leg length was related to lower risk among men and women, but only among men if adjusted for total height. Adjustment for liver fat and triacylglycerols, adiponectin and C-reactive protein substantially attenuated associations between height and diabetes risk, particularly among women. Conclusions/interpretation We observed inverse associations between height and risk of type 2 diabetes, which was largely related to leg length among men. The inverse associations may be partly driven by lower liver fat content and a more favourable cardiometabolic profile.
Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes
(2019)
Recent studies suggest that insulin-like growth factor binding protein 2 (IGFBP-2) may protect against type 2 diabetes, but population-based human studies are scarce. We aimed to investigate the prospective association of circulating IGFBP-2 concentrations and of differential methylation in the IGFBP-2 gene with type 2 diabetes risk.